stoxline Quote Chart Rank Option Currency Glossary
  
Exscientia plc (EXAI)
4.32  0.07 (1.65%)    04-17 16:00
Open: 4.26
High: 4.3586
Volume: 561,855
  
Pre. Close: 4.25
Low: 4.2
Market Cap: 543(M)
Technical analysis
2024-04-17 4:46:32 PM
Short term     
Mid term     
Targets 6-month :  6.82 1-year :  8.02
Resists First :  5.84 Second :  6.87
Pivot price 4.93
Supports First :  4.17 Second :  3.46
MAs MA(5) :  4.49 MA(20) :  5.23
MA(100) :  6.01 MA(250) :  6.09
MACD MACD :  -0.5 Signal :  -0.4
%K %D K(14,3) :  4.9 D(3) :  7.3
RSI RSI(14): 32.2
52-week High :  9.11 Low :  4.17
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ EXAI ] has closed above bottom band by 15.5%. Bollinger Bands are 11.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.36 - 4.39 4.39 - 4.41
Low: 4.14 - 4.17 4.17 - 4.2
Close: 4.27 - 4.32 4.32 - 4.36
Company Description

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Headline News

Thu, 21 Mar 2024
Exscientia Plc Reports Progressive Drug Pipeline - TipRanks.com - TipRanks

Thu, 21 Mar 2024
Exscientia plc (EXAI) Q4 2023 Earnings Call Transcript - Seeking Alpha

Thu, 21 Mar 2024
Exscientia Business and Financial Update for the Full Year 2023 - Business Wire

Tue, 19 Mar 2024
Exscientia plc's (NASDAQ:EXAI) market cap touched US$797m last week, benefiting both individual investors who own ... - Yahoo Finance

Thu, 14 Mar 2024
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024 - Yahoo Finance

Mon, 11 Mar 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAI - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 126 (M)
Held by Insiders 9.258e+007 (%)
Held by Institutions 26.4 (%)
Shares Short 3,230 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.6252e+008
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 789.9 %
Return on Equity (ttm) -18.8 %
Qtrly Rev. Growth 2.008e+007 %
Gross Profit (p.s.) -82.44
Sales Per Share -44.85
EBITDA (p.s.) 0
Qtrly Earnings Growth -1.5 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -118 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.1
Price to Cash Flow 1.19
Stock Dividends
Dividend 0
Forward Dividend 4.36e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android